NCT06666803View on ClinicalTrials.gov

Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

February 28, 2027

Conditions
PDAC - Pancreatic Ductal Adenocarcinoma
Interventions
OTHER

FNB sampling

A supplementary FNB will be performed during the EUS procedure. Sample will be processed to obtain organoids and assess their morphological, proliferative and genetics characteristics.

BIOLOGICAL

blood sampling

A blood withdrawal will be performed during the EUS procedure. Sample will be processed to assess organoids morphological, proliferative and genetics characteristics.

Trial Locations (1)

Unknown

Department of hepato-gastroenterology, Strasbourg

All Listed Sponsors
collaborator

Luxembourg Institute of Health

OTHER_GOV

lead

IHU Strasbourg

OTHER

NCT06666803 - Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB) | Biotech Hunter | Biotech Hunter